نتایج جستجو برای: 839

تعداد نتایج: 1134  

2017
Ravyn M. Thompson Dominik Dytfeld Leticia Reyes Reeder M. Robinson Brittany Smith Yefim Manevich Andrzej Jakubowiak Mieczyslaw Komarnicki Anna Przybylowicz-Chalecka Tomasz Szczepaniak Amit K. Mitra Brian G. Van Ness Magdalena Luczak Nathan G. Dolloff

Curative responses in the treatment of multiple myeloma (MM) are limited by the emergence of therapeutic resistance. To address this problem, we set out to identify druggable mechanisms that convey resistance to proteasome inhibitors (PIs; e.g., bortezomib), which are cornerstone agents in the treatment of MM. In isogenic pairs of PI sensitive and resistant cells, we observed stark differences ...

2012
Jamey Graham

(51) Int. Cl. G06F 3/00 (2006.01) G06F 3/14 (2006.01) (52) U.S. Cl. ...................... 715/839; 715/716; 715/719; 715/764; 715/835; 715/838; 715/500.1; 715/526; 358/540 (58) Field of Classification Search ................ 345/700, 345/716,717,719,727,764,835,838,839, 345/855; 358/1.1,1.15,1.18,530,540; 705/55; 715/479,500,500.1,501.1,513,526,527, 715/700,716,717,719,727,764,835,838, 715/839...

2013
Lenore K. Beitel Parsa Kazemi-Esfarjani Morris Kaufman Angelo M. DiGeorge

We aim to correlate point mutations in the androgen receptor gene with receptor phenotypes and with clinical phenotypes of androgen resistance. In two families, the external genitalia were predominantly female at birth, and sex-ofrearing has been female. Their androgen receptor mutation changed arginine-839 to histidine. In a third family, the external genitalia were predominantly male at birth...

2007
Kenneth J. Leib Susan E. Finger

......................................................................................................................................................839 Introduction.................................................................................................................................................839 Purpose and Scope ...................................................................

Journal: :Molecular cancer therapeutics 2014
Matt I Gross Susan D Demo Jennifer B Dennison Lijing Chen Tania Chernov-Rogan Bindu Goyal Julie R Janes Guy J Laidig Evan R Lewis Jim Li Andrew L Mackinnon Francesco Parlati Mirna L M Rodriguez Peter J Shwonek Eric B Sjogren Timothy F Stanton Taotao Wang Jinfu Yang Frances Zhao Mark K Bennett

Glutamine serves as an important source of energy and building blocks for many tumor cells. The first step in glutamine utilization is its conversion to glutamate by the mitochondrial enzyme glutaminase. CB-839 is a potent, selective, and orally bioavailable inhibitor of both splice variants of glutaminase (KGA and GAC). CB-839 had antiproliferative activity in a triple-negative breast cancer (...

Journal: :Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2017
Luis H Braga Armando J Lorenzo Rodrigo L P Romao

A search of MEDLINE, Cochrane, and EMBASE databases and conference proceedings (January 1988‒December 2015) were included to evaluate data and select pertinent articles on the topic. Search terms included cryptorchidism or undescended testicle as the topic of interest with an English language limit. Retrospective and prospective study designs, case series, review articles, and consensus stateme...

Journal: :American Journal of Obstetrics and Gynecology 2020

Journal: : 2022

Zeitschrift für ausländisches öffentliches Recht und Völkerrecht / Heidelberg Journal of International Law , Seite 839 - 844

2016
Sarah C. Zimmermann Emily F. Wolf Andrew Luu Ajit G. Thomas Marigo Stathis Brad Poore Christopher Nguyen Anne Le Camilo Rojas Barbara S. Slusher Takashi Tsukamoto

A series of allosteric kidney-type glutaminase (GLS) inhibitors were designed and synthesized using 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)butane as a core scaffold. A variety of modified phenylacetyl groups were incorporated into the 5-amino group of the two thiadiazole rings in an attempt to facilitate additional binding interactions with the allosteric binding site of GLS. Among the newly synt...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید